FDA Investigator

Richard Ledwidge

Latest inspection on record: Hillerod, Denmark, November 2024 · records back to 2017

Human Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 31 inspections across 31 sites are on record.
  • 2 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2024-11-12.

At a glance

Inspections

31

Sites

31

Observations

2

Career since

May 2017

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
FUJIFILM Diosynth Biotechnologies Denmark ApS12 Nov 2024Human DrugsOn file
Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse)20 Sep 2024Human DrugsOn file
Biocon Biologics Limited26 Jul 2024Human DrugsOn file
CSL Behring GmbH30 Apr 2024Human DrugsOn file
Roche Diagnostics GmbH20 Mar 2024Human DrugsOn file

Sites inspected

FUJIFILM Diosynth Biotechnologies Denmark ApSHillerod, Denmark1 insp.
Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse)Ravensburg, Germany1 insp.
Biocon Biologics LimitedBengaluru, India1 insp.
CSL Behring GmbHMarburg, Germany1 insp.
Roche Diagnostics GmbHMannheim, Germany1 insp.

Co-investigators

Investigators who share inspections with this person.

Lei Zhang2 shared
Zhong Li2 shared
Xiaoshi Wang1 shared
Charles Y Kuo1 shared
David D Anderson1 shared
Teresa I Navas1 shared
Yiwei Li1 shared

Full investigator report

Get the verbatim findings behind Richard Ledwidge's 2 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators